Risk of invasive adenocarcinoma of the cervix following treatment of adenocarcinoma in situ (ais): Can cotesting identify a group for which subsequent hysterectomy is not mandatory?
2017 ◽
Vol 26
(1)
◽
pp. 4-11
◽
2021 ◽
Vol 39
(15_suppl)
◽
pp. e13535-e13535
2020 ◽
Vol 101
(12)
◽
pp. 831-837
2002 ◽
Vol 21
(4)
◽
pp. 314-326
◽
2012 ◽
Vol 125
(3)
◽
pp. 589-593
◽
2001 ◽
Vol 13
(5)
◽
pp. 394-398
◽
2014 ◽
Vol 38
(4)
◽
pp. 448-460
◽